PolyPeptide Group AG (XSWX:PPGN) FFO


XSWX:PPGN PolyPeptide Group AG XSWX:PPGN
69 GF Score
Price CHF46.50
GF Value CHF30.72
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is PolyPeptide Group AG FFO?

FFO (Funds from operations) only applies to REITs.

XSWX:PPGN
69GF Score
PolyPeptide Group AG XSWX:PPGN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PolyPeptide Group AG (XSWX:PPGN) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of CHF46.50 is trading 51.4% above its estimated GF Value™ of CHF30.72. GuruFocus considers PolyPeptide Group AG to be Significantly Overvalued.

Key valuation signals for XSWX:PPGN:

  • FFO:
  • GF Value™: CHF30.72 vs. price of CHF46.50 (51.4% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the XSWX:PPGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
69GF Score

Get the complete analysis for XSWX:PPGN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF46.50
Price
CHF30.72
GF Value